Mind Studio Biotech ApS — Credit Rating and Financial Key Figures
CVR number: 43618075
Rantzausgade 8 B, 2200 København N
Income statement (kDKK)
2023 | 2024 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 124.19 | 912.19 |
| Employee benefit expenses | -94.03 | - 901.96 |
| Total depreciation | -0.87 | -1.27 |
| EBIT | 29.28 | 8.96 |
| Other financial expenses | -0.78 | |
| Pre-tax profit | 29.28 | 8.17 |
| Income taxes | -6.58 | -2.02 |
| Net earnings | 22.70 | 6.15 |
Assets (kDKK)
2023 | 2024 | |
|---|---|---|
| Intangible rights | 9.27 | 14.85 |
| Intangible assets total | 9.27 | 14.85 |
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Raw materials and consumables | 5.63 | 202.98 |
| Inventories total | 5.63 | 202.98 |
| Current trade debtors | 136.19 | 24.75 |
| Prepayments and accrued income | 11.60 | |
| Short term receivables total | 136.19 | 36.34 |
| Cash and bank deposits | 45.08 | 62.58 |
| Cash and cash equivalents | 45.08 | 62.58 |
| Balance sheet total (assets) | 196.17 | 316.75 |
Equity and liabilities (kDKK)
2023 | 2024 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Retained earnings | 22.70 | |
| Profit of the financial year | 22.70 | 6.15 |
| Shareholders equity total | 62.70 | 68.85 |
| Non-current liabilities total | ||
| Current trade creditors | 19.19 | 12.28 |
| Short-term deferred tax liabilities | 6.58 | 2.02 |
| Other non-interest bearing current liabilities | 107.70 | 233.59 |
| Current liabilities total | 133.47 | 247.90 |
| Balance sheet total (liabilities) | 196.17 | 316.75 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.